Poster Walk and Get Together 13
Pharmacoepidemiology and drug safety

Programm

• • Poster Self-Study
  • P160

  Rescue therapy for supratherapeutic concentrations of calcineurin inhibitors using potent cytochrome P450 inducers

  • Seth Duwor (Zurich / CH)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P161

  Pharmaceutical intervention to increase drug treatment safety in polymedicated patients in an acute geriatric ward of a university hospital in Germany

  • Jan Matthes (Cologne / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P162

  Study of antipsychotics medication of schizophrenia patients with stable neuroleptic treatment in outpatient care

  • Jens-Uwe Peter (Rüdersdorf / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P163

  Melatonin – food supplement or drug: analytical method validation and first data from porcini mushrooms

  • Reinhard Oertel (Dresden / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P164

  Clinical‑pharmacological drug information center of Hannover Medical School: experiences and analysis from a tertiary care university hospital

  • Johannes Heck (Hannover / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P165

  The symptomatology of medication error caused ADRs leading to emergency department visits

  • Justyna Wozniak (Aachen / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P166

  Pseudo-worsening of renal function due to inhibition of transporter-mediated renal secretion of creatinine: Overview of perpetrating drugs and insights from US, UK and German Summaries of Product Characteristics (SmPCs)

  • Michael Sponfeldner (Erlangen / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P167

  Individual Use of Self-medication and other Remedies in COVID-19 Outpatients in Western-Pomerania

  • Svea Stüdemann (Greifswald / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P168

  Intersecting Pathways: Amphetamines and Opioids in the Landscape of Chronic Pain Therapy

  • Maria Antonia Balan (Targu Mures / RO)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P169

  Participative view on benefit/risk in antidepressive medication: comparison of patients" awareness in a geriatric vs. psychiatric hospital

  • Jason Radermacher (Aachen / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P170

  Drug-associated anaphylactic reactions in Germany: A complementary descriptive analysis of cases from the Anaphylaxis-Registry and spontaneous reports from the European Adverse Reaction Database (EudraVigilance)

  • Patrick Christ (Bonn / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P171

  Analysis of spontaneous adverse drug reaction reports related to fluoroquinolones before and after regulatory restrictions

  • Diana Dubrall (Bonn / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P172

  Are medication errors in oral antitumor therapy comparable between data from the randomized AMBORA trial and clinical routine?

  • Lisa Cuba (Erlangen / DE)

   Pharmacoepidemiology and drug safety
• • Poster Self-Study
  • P173

  Medication safety in paediatric oncology: Benefit of integrating a clinical pharmacist into an interprofessional treatment team

  • Phyllis Lensker (Erlangen / DE)

   Pharmacoepidemiology and drug safety